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Abstract 27 
Objective: While impaired renal function has been a frequent finding among adult patients with 28 
intestinal failure (IF), the data on children is scarce. This study aimed to assess renal function 29 
in pediatric-onset IF.  30 
Methods: Medical records of 70 patients (38 boys) with pediatric onset IF due to either short 31 
bowel syndrome (SBS, n=59) or primary motility disorder (n=11) and a history of parenteral 32 
nutrition (PN) dependency for at least one month were evaluated. Renal function at the most 33 
recent follow-up was studied using plasma creatinine, cystatin C and urea concentrations and 34 
estimated glomerular filtration rate (eGFR).  35 
Results: At a median age of 5.7 and after PN duration of 3.2 years, twenty (29%) patients had 36 
decreased eGFR and higher cystatin C and urea concentrations. Patients with decreased renal 37 
function had significantly longer duration of PN (3.2 years versus 0.9 years, p=0.030) and 38 
shorter percentage of age-adjusted small bowel length remaining (22% versus 32%, p=0.041) 39 
when compared to patients with preserved renal function. No other predisposing factors for 40 
decreased eGFR were identified.  41 
Conclusions: Patients with pediatric onset IF are at significant risk of impaired renal function, 42 
which associated with the severity of SBS. Further studies using measured GFR are needed. 43 
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 53 
Background 54 
The European Society of Clinical Nutrition and Metabolism has defined intestinal failure (IF) 55 
as the reduction of gut function below the minimum necessary for the absorption of 56 
macronutrients, water and electrolytes, so that intravenous supplementation is required to 57 
maintain health and growth [1]. In pediatric patients, necrotizing enterocolitis, intestinal atresia, 58 
mid-gut volvulus, gastroschisis, Hirschsprung disease and intestinal pseudo-obstruction (CIPO) 59 
causing either short bowel syndrome (SBS) or severe intestinal dysmotility are the most 60 
common etiologies for IF [2,3]. 61 
 62 
Patients with IF are at persistent risk of hypovolemia and electrolyte imbalance due to impaired 63 
absorption and increased intestinal losses, recurrent sepsis episodes and nephrotoxic 64 
medications, which may have an adverse effect on kidney function. Impaired kidney function 65 
and development of chronic renal failure have been reported in adult patients with long-term 66 
parenteral nutrition for IF [4-7] whereas data on renal function in children with IF is very limited 67 
[8,9]. Chronic renal failure is observed earlier and more frequently following intestinal 68 
transplantation when compared to other solid organ transplantations [10]. The golden standard 69 
for evaluating renal function is to measure the glomerular filtration rate (mGFR) using either 70 
inulin or some other radio-labeled marker, such as ethylenediamine tetracetic acid labeled 71 
chromium-51 (51Cr-EDTA). Due to the costs and complexities of measuring GFR, estimated 72 
GFR, plasma creatinine and cystatin C are often used in clinical practice to assess renal 73 
function. Renal function is considered to be impaired if GFR is < 90mL/min/1.73m2 in adults 74 
and children older than two years of age [11]. The aim of the present study was to assess the 75 
renal function in children with IF during and after weaning off PN. 76 
 77 
 78 
 79 
 80 
Materials and methods 81 
The study comprised patients with pediatric onset IF treated and followed up at the Children’s 82 
Hospital, Helsinki University Hospital, between the years 1990 and 2015. All patients with IF 83 
due to either SBS or primary intestinal dysmotility disorders and with parenteral nutrition (PN) 84 
for at least for one month and a follow-up period of at least one year were included. In total, 78 85 
eligible patients were identified; eight of them were excluded from the study because of 86 
incomplete laboratory values.  87 
 88 
Patient’s age, sex, primary disease, cause of IF, surgical procedures, number of blood culture 89 
positive sepsis episodes, anatomy of the remaining bowel, duration of PN, and the amount of 90 
current PN as well as weight and height at the most recent follow-up were collected from the 91 
patient records. Sepsis episode details could be reliably extracted from the electronic hospital 92 
discharge database from the year 1993 onwards. Six out of the 70 patients were born before 93 
1993, and data on their early sepsis episodes may therefore not be complete.  94 
 95 
Growth was assessed using the Finnish national growth charts. The height is given as z scores 96 
and weight as age-adjusted ISO-BMI scores for patients ≥ 2 years. Height was corrected for 97 
gestational age if needed. Age-adjusted weight-to-height percentiles (based on the national 98 
data) are reported for those < 2 years [12]. Three patients with cartilage-hair hypoplasia and 99 
one patient with Down syndrome-associated growth failure were excluded from the height 100 
analysis. The percentage of the remaining age-adjusted small bowel and colon length was 101 
calculated based on age-specific normal in vivo values [13]. Hirschsprung disease patients with 102 
less than 50% of age-adjusted small bowel length remaining were categorized to the SBS group. 103 
 104 
Renal function laboratory parameters (plasma creatinine, cystatin C and urea) measured at the 105 
time of the most recent follow-up visit were collected from the medical records; the follow-up 106 
time was considered to end at this point. Renal function was evaluated using either the estimated 107 
glomerular filtration rate (eGFR) calculated by the CKID Schwartz equation [14], which uses 108 
all creatinine, cystatin C and urea values in the formula or the CKD-EPI Creatinine-Cystatin 109 
equation [15] for patients older than 18 years of age. In two cases lacking cystatin C value, 110 
creatinine-based Bedside Schwartz formula was used [16]. In four cases with decreased renal 111 
function, GFR had been evaluated more precisely using 51Cr-EDTA measurement. Renal 112 
function was classified as normal when eGFR was ≥ 89 mL/min/1.73m2 (≥ 62 mL/min/1.73m2 113 
at the age of 12 to 19 months) [17]. In patients who underwent intestinal transplantation during 114 
follow-up, renal function was evaluated before the surgery. Renal ultrasound had been 115 
performed on all patients with decreased renal function. The possible presence of structural 116 
abnormalities, nephrocalcinosis and/or increased echogenicity was recorded from the medical 117 
records and ultrasound pictures.  118 
 119 
Statistical analysis 120 
All statistical analyses were performed using the Statistical Package for the Social Sciences 121 
(SPSS/Windows version 22.0, SPSS Inc., Chicago, IL, USA). Data are reported as medians 122 
with their interquartile range. A Mann-Whitney U test was used to compare median values. 123 
Fisher’s exact test was used for comparison of categorical variables. Statistical significance was 124 
defined as P ≤ 0.05.  125 
 126 
Ethics 127 
The Ethical Committee of the Children’s Hospital, University of Helsinki, approved the use of 128 
patient’s information and the study protocol.  129 
 130 
 131 
Results 132 
The demographics and clinical characteristics of the patient population are summarized in 133 
Table 1. The causes of IF included necrotizing enterocolitis (n=20), mid-gut volvulus (n=15), 134 
small bowel atresia (n=14), gastroschisis (n=2), CIPO (n=8), and Hirschsprung’s disease 135 
(n=11); eight of these were categorized to the SBS group. At the latest follow-up visit, 22 of 136 
the 70 (31%) patients were on PN and received a median 7 (6-7) weekly PN infusions. Five 137 
patients have undergone intestinal transplantation and three are currently on waiting list for 138 
transplantation. 139 
 140 
 141 
Table 1. Patient characteristics of 70 patients with pediatric onset IF having either normal or 142 
decreased GFR at the end of the follow-up. 143 
________________________________________________________________________________144 
     All patients  Patients with    Patients with      P-value145 
       decreased GFR* normal GFR* 146 
________________________________________________________________________________ 147 
N     70   20   50  148 
Boys     38   10   28      0.792 149 
Age/Follow-up time (yrs)   5.4 (3.3-12.3)  5.7 (3.0-12.1)  5.4 (3.6-14.2)     0.563 150 
Height (z score)  -1.4 (-2.3 to -0.4) -2.5 (-3.2 to -0.7) -1.1 (-2.0 to -0.1) 0.027 151 
Weight (ISO-BMI)   19.6 (17.3-22.0) 20 (18.9-22.4)  19.2 (16.4-21.9)   0.207 152 
Weight (percentiles)   -9% (-11 to -0) 0   -9 % (-11 to-2)    0.667 153 
SBS/Dysmotility disorder  59/11   19/1   40/10      0.159 154 
Patients weaned off PN   48   12   36      0.397 155 
Time after weaning off PN (yrs) 4.5 (2.2-9.7) 4.0 (1.7-7.1)  4.9 (2.3-10.7)     0.338 156 
Duration of PN (months) 14.7 (6.3-40.0) 38.7 (11.5-99.2) 11.1 (5.2-32.0)    0.030 157 
Amount of curr. PN (kcal/kg/day) 41.5 (30.7-60) 50.5 (35.3-74.7) 38.4 (30.0-45.0)   0.297 158 
N of septicemia/patient 1.0 (0.0-2.0)  0.0 (0.0-3.5)  1.0 (0.0-2.0)      0.863 159 
Remaining bowel 160 
 Small bowel (cm) 50 (30-100)  36 (23-65)  50 (31-103)     0.364 161 
 Small bowel (%) 26 (17-53)  22 (16-32)  32 (21-75)     0.041 162 
 Colon (%)  77 (50-100)  72 (3-100)  82 (50-100)     0.462 163 
 Colon +/-  45/15   14/6   41/9      0.337 164 
 ICV preserved  34   7   26      0.290 165 
Plasma creatinine µmol/L 33 (24-48)  43 (28-53)  30 (22-46)     0.062 166 
Plasma cystatin C mg/L 0.85 (0.74-0.98) 0.99 (0.90-1.18) 0.76 (0.72-0.86)   <0.001 167 
Plasma urea mmol/L  4.9 (3.9-6.6)  6.8 (4.8-7.2)  4.5 (3.7-5.2)     <0.01 168 
eGFR mL/min/1.73m2 100 (86-115)  71 (65-86)  107 (99-124)     <0.001 169 
________________________________________________________________________________ 170 
Curr. = current, eGFR = estimated glomerular filtration rate, ICV = ileocecal valve, ISO-BMI = 171 
age-adjusted BMI, N =  number, SBS = short bowel syndrome, PN = parenteral nutrition, yrs = 172 
years. *Renal function was classified as normal when eGFR was ≥ 89ml/min/1.72m2 (≥ 62 173 
mL/min/1.73m2 at the age of 12 to 19 months) [17]. 174 
 175 
Overall, 20 (29%) patients had decreased eGFR at a median age of 5.7 years after median PN 176 
duration of 3.2 years (Table 1). Patients with decreased eGFR had also significantly higher 177 
cystatin C and urea values. The increase in creatinine levels failed to reach statistical 178 
significance. Among patients with decreased renal function, eGFR was 60-89 mL/min/1.73m2 179 
in 16 (80%) patients and below 60mL/min/1.73m2 in four (20%) patients. There was no 180 
difference between patients treated in 1990–2000 to those treated in 2000–2015, the mean GFR 181 
being 108 versus 97 mL/min/1.73m2 (p=0.395). 182 
 183 
The duration of PN was significantly longer among patients with decreased eGFR when 184 
compared to patients with normal renal function (Table 1). The duration of PN remained 185 
significantly longer among patients with decreased eGFR also after patients with CIPO or 186 
Hirschprung disease with more than 50% of age-adjusted small bowel length remaining were 187 
excluded from the analysis (p=0.020). The percentage of age-adjusted length of the remaining 188 
small bowel was also significantly lower in patients with decreased renal function than in 189 
patients with normal GFR (Table 1). Patients with decreased renal function were also shorter 190 
than patients with normal renal function (Table 1). There was no association between the cause 191 
of IF, current PN delivery, the follow-up time after weaning off PN, the number of blood 192 
culture-positive sepsis episodes, weight, the absolute length of remaining small bowel, 193 
remaining colon or the presence of ileocecal valve and decreased eGFR (Table 1). None of the 194 
patients with decreased renal function had a history of any renal disease or anomaly, renal 195 
stones, or had nephrocalcinosis on their last ultrasound.  196 
 197 
Of the eight patients who had received (n=5) or were listed (n=3) for intestinal transplantation 198 
after a median of 90 (7–170) PN months, five showed decreased GFR in the evaluations 199 
performed at listing. Of the five patients with decreased GFR, four had Hirschsprung disease 200 
and one had NEC with 16%, 21%, 25%, 25% and 23% of remaining small intestine, 201 
respectively, and the median duration of PN was 99 months (80-153). Among the five patients 202 
with decreased renal function, median GFR was 66 (49–67) mL/min/1.73m2 measured using 203 
51Cr-EDTA measurement in four of these cases.  204 
 205 
 206 
Discussion 207 
In this study, we found that renal function was impaired in 20 out of a total of 70 (29%) patients 208 
with pediatric onset IF after a median follow-up time of 5.3 years. Prolonged duration of PN 209 
and a short proportion of remaining small bowel were found to be associated with the decreased 210 
kidney function, suggesting that the severity of IF plays an important role. To our best 211 
knowledge, there are only two previous studies available on renal function in children with IF 212 
and/or with prolonged PN. According to the report by Moukarzel et al. including 13 children 213 
on long-term PN, all patients had impaired renal function (GFR 65.5±11.9 mL/min/1.73m2) at 214 
a mean age of 9.0 ± 4.9 years [9]. The authors also found that in children with long-term PN, 215 
the duration of PN was inversely correlated with GFR, similarly to the study carried out by 216 
Buchman et al. [5,9]. Recently, Kosar et al. published a study where they evaluated kidneys of 217 
54 children with IF using serum creatinine and urea and urine oxalate, creatinine and calcium 218 
as biochemical parameters and renal ultrasonography. According to their report, a large 219 
proportion of the patients had increased echogenicity/nephrocalcinosis on ultrasonography 220 
analysis. Increased echogenicity/nephrocalcinosis was associated with prolonged PN exposure 221 
[8]. The authors did not report decreased renal function in any of the patients, but they did not 222 
measure GFR or calculate eGFR. Studies among adult IF patients have provided evidence for 223 
decreased renal function and a relatively high frequency of chronic renal failure [4-7]. Buchman 224 
et al. found a progressive impairment of renal function during prolonged PN. The rate of decline 225 
in creatinine clearance was 3.5 ± 6.3% per year [5]. In another study, renal function was studied 226 
in 33 patients on long-term PN and in 22 patients after intestinal transplantation. Chronic renal 227 
failure was found in 21% of the PN-dependent patients and in 54% of the transplanted patients 228 
[7]. Significant deterioration of kidney function also occurs following intestinal transplantation 229 
in children [10]. These findings are reinforced by the present study showing impaired renal 230 
function in a significant proportion of children with IF even after weaning off PN and in 5 out 231 
of 8 patients at listing for intestinal transplantation.  232 
 233 
The pathophysiology of chronic renal failure in IF patients remains unclear.[4] It is most likely 234 
of multifactorial origin. Possible dehydration episodes, nephrolithiasis, repeated septicemias 235 
and exposure to nephrotoxic antimicrobial medication may all gradually deteriorate kidney 236 
function. The deterioration could be partly due to more novel mechanisms such as chronic low-237 
grade renal inflammation induced by bacterial products, which translocate through leaky 238 
intestinal epithelium in SBS. In a study carried out by Lauverjat et al., 21 out of 40 (53%) adults 239 
with IF had a significant reduction in renal function, with a hypovolemic component in over 240 
70% of the cases [6]. In addition to dehydration, the presence of urologic or nephrologic 241 
diseases was also found to be a risk factor for chronic renal failure [6]. There is also some 242 
evidence suggesting that episodes of bacteremia and fungemia during PN are associated with a 243 
decline in GFR [5]. In this study, the number of blood culture-positive episodes of bacteremia 244 
or fungemia was not found to be associated with decreased renal function. The risk of calcium 245 
oxalate stones and/or nephrocalcinosis has also been found to be increased in patients with SBS 246 
and retained colon, which may lead to impairment of renal function [18]. The role of PN in the 247 
genesis of renal stones has been attributed to the acidity of solution and to the presence of 248 
vitamin C in PN, which leads to formation of urine oxalate formation [19]. Low calcium intake, 249 
vitamin D and hyperparathyreosis and the presence of lipid in the PN preparations can also have 250 
on impact on oxalate levels [20]. In this study, none of our patients with decreased renal 251 
function had nephrocalcinosis on ultrasonography or a history of kidney stones. Here, decreased 252 
renal function was equally prevalent during PN-dependency and after weaning off PN, 253 
highlighting the importance of close and continuing surveillance of kidney function in children 254 
with IF also after weaning off PN. The role of the amount of protein in the PN has also been 255 
studied in one earlier study, but no association between renal function and protein load was 256 
found [6].  257 
 258 
In this study, patients with decreased renal function were shorter than patients with normal 259 
eGFR, suggesting that the growth of these patients has also been impacted by either the severity 260 
of IF or renal impairment. However, most of the patients with decreased renal function were 261 
not uremic, indicating a non-renal etiology in most cases.  262 
 263 
Our patient material is one of the largest describing renal function in patients with IF. The study 264 
has, however, some limitations/weaknesses. As in the earlier study by Pironi et al. [7], we 265 
mainly used eGFR to evaluate renal function because measured GFR was not available from 266 
majority of the patients. In the recent study by Kosar et al. [8], creatinine alone was used to 267 
measure the glomerular function. In patients with IF, growth and muscle mass may be 268 
decreased, rendering creatinine alone an unreliable parameter of renal function, as was also 269 
shown in this study. Here, we measured plasma cystatin C and urea concentrations almost 270 
exclusively and used the CKiD formula, which has been shown to correlate better with mGFR 271 
than formulas based only on creatinine or cystatin C concentration [14,21,22]. In the future, 272 
further studies measuring actual GFR in these patients are needed. Another caveat is that 273 
accurate information about the use of nephrotoxic medication was not available and we were 274 
thus unable to analyze possible associations between medication and renal function. Our 275 
hospital is a tertiary hospital and many of the study patients were managed at their local hospital 276 
between the follow-up visits. The possible impact of nephrotoxic medication has been evaluated 277 
in three earlier studies, suggesting that the medication does not have major impact on renal 278 
function [5,8,9].  279 
 280 
Conclusions 281 
In conclusion, patients with pediatric onset IF are at significant risk of impaired renal function, 282 
which, associated with the severity of SBS, may promote the development of chronic renal 283 
failure after intestinal transplantation. Therefore, evaluation of renal function of these patients 284 
is warranted.  285 
 286 
 287 
 288 
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